Neurosurgical emergency in a 23-year-old woman treated with rivaroxaban: How to manage anticoagulation?
Type de matériel :
TexteLangue : français Détails de publication : 2022.
Ressources en ligne : Abrégé : The management of patients treated with factor Xa inhibitors (rivaroxaban or apixaban) with severe bleeding is currently based on the use of hemostatic agents such as prothrombin complex concentrates (PCC) or activated PCC, as proposed by the French Working Group on Perioperative Hemostasis (Groupe d’intérêt sur l’hémostase péri-opératoire, GIHP). Here, we report the case of a neurosurgical emergency involving a young patient treated with a curative dose of rivaroxaban and requiring emergency reversal of anticoagulation for a rapidly evolving tetraparesis.
Nous n'avons pas d'exemplaire de ce document
56
The management of patients treated with factor Xa inhibitors (rivaroxaban or apixaban) with severe bleeding is currently based on the use of hemostatic agents such as prothrombin complex concentrates (PCC) or activated PCC, as proposed by the French Working Group on Perioperative Hemostasis (Groupe d’intérêt sur l’hémostase péri-opératoire, GIHP). Here, we report the case of a neurosurgical emergency involving a young patient treated with a curative dose of rivaroxaban and requiring emergency reversal of anticoagulation for a rapidly evolving tetraparesis.
Réseaux sociaux